HARVARD BIOSCIENCE INC — Director's Dealing 2014

Aug 6, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-08-05

Reporting Person: LEWIS EARL R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-05	Common Stock	M	45090	$2.59	Acquired	229248	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-05	Stock option (right to buy)	$2.59	M	45090	Disposed	2020-06-04	Common stock, par value $0.01 per share (45090)	Direct

Footnotes

F1: Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 206,160 shares of common stock held by the Reporting Person.

F2: Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended.

F3: The options vested in three equal installments on June 4, 2011, 2012 and 2013.